20 May 2026
Cancers Webinar | DNA Damage Response Pathways in Cancer and Therapy, 1 June 2026
Welcome message from the Chair:
The DNA Damage Response (DDR) represents one of the most vibrant and rapidly evolving fields in cancer research. What began as fundamental inquiries into the mechanisms of genomic stability has transformed into a robust pipeline of therapeutic strategies, from PARP inhibitors to emerging immunotherapy agents. Today, the study of DDR pathways sits at a fascinating intersection: it is central to our understanding of tumor suppression, a key determinant of response to conventional therapies, and a rich source of novel drug targets.
Over the next 3 hours, we will explore the full spectrum of this field. Our program connects the molecular architecture of repair complexes with the translational challenges of overcoming therapeutic resistance. We will delve into the complexities of synthetic lethality, the interplay between DDR deficiencies and the tumor microenvironment, and the promise of combining DDR inhibitors with immunotherapies.
Date: 1 June 2026 at 2:00 p.m. CEST | 8:00 a.m. EDT | 8:00 p.m. CST Asia
Webinar ID: 847 6925 5911
Landing page: https://sciforum.net/event/Cancers-13?subscribe
Register now for free!
Program
| Speaker | Presentation Title | Time in CEST | Time in EDT | Time in CST Asia |
| Prof. Guomin Li | Chair Introduction | 2:00–2:10 p.m. | 8:00–8:10 a.m. | 8:00–8:10 p.m. |
| Prof. Dr. Vincenzo Costanzo | The Expanding Roles of Homologous Recombination Proteins in Genome Stability | 2:10–2:50 p.m. | 8:10–8:50 a.m. | 8:10–8:50 p.m. |
| Prof. Dr. Ting Liu | Targeting Replication Stress Responses in Cancer Therapy | 2:50–3:30 p.m. | 8:50–9:30 a.m. | 8:50–9:30 p.m. |
| Prof. Dr. Zhongsheng You | A Novel TRPV2-STING Axis for Genome and Immune Defense | 3:30–4:10 p.m. | 9:30–10:10 a.m. | 9:30–10:10 p.m. |
| Q&A Session | 4:10–4:25 p.m. | 10:10–10:25 a.m. | 10:10–10:25 p.m. | |
| Prof. Guo-Min Li | Webinar closure | 4:25–4:30 p.m. | 10:25–10:30 a.m. | 10:25–10:30 p.m. |
After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register and we will let you know when the recording is available to watch.
Webinar Chair and Keynote Speakers:
- Guo-Min Li, Institute for Cancer Research, Chinese Institutes for Medical Research, Beijing, China;
- Ting Liu, Zhejiang University, Hangzhou, China;
- Vincenzo Costanzo, University of Milan, Milan, Italy;
- Zhongsheng You, Chinese Institutes for Medical Research, Beijing, China.
